0001576280-21-000090.txt : 20210914 0001576280-21-000090.hdr.sgml : 20210914 20210914170732 ACCESSION NUMBER: 0001576280-21-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210910 FILED AS OF DATE: 20210914 DATE AS OF CHANGE: 20210914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERESMAN STANLEY J CENTRAL INDEX KEY: 0001283102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 211253117 MAIL ADDRESS: STREET 1: 2071 HUNTINGTON LANE CITY: LOS ALTOS STATE: CA ZIP: 94024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_163165363552010.xml FORM 4 X0306 4 2021-09-10 0 0001576280 Guardant Health, Inc. GH 0001283102 MERESMAN STANLEY J 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 0 0 0 COMMON STOCK 2021-09-10 4 M 0 4934 5.94 A 8993 D COMMON STOCK 2021-09-10 4 S 0 3052 129.3101 D 5941 D COMMON STOCK 2021-09-10 4 S 0 1082 130.1116 D 4859 D COMMON STOCK 2021-09-10 4 S 0 800 131.12 D 4059 D STOCK OPTION (RIGHT TO BUY) 5.94 2021-09-10 4 M 0 4934 0 D 2028-05-09 COMMON STOCK 4934.0 39473 D These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.85 to $129.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.86 to $130.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. /s/ John Saia, as attorney-in-fact for Stanley J Meresman 2021-09-14